Cryoport and CCRM Fertility Enter Into Agreement

IndustryPRwire -- Cryoport announced a three-year agreement with the Colorado Center for Reproductive Medicine, a global pioneer in fertility science, research and advancement. Under the terms of the agreement, Cryoport's temperature-controlled solutions will support CCRM's fertility treatments, including in vitro fertilization (IVF), fertility preservation, third-party reproduction and egg donation.

CCRM will utilize Cryoport's world-class temperature-controlled supply chain management and informatics platform to process cryogenic shipments of human eggs and embryos throughout its network with the mission of helping intended parents grow their families.  CCRM's network is made up of 11 centers in North America staffed by over 40 physicians, 22 PhD's and 560 dedicated employees.  In addition to Cryoport assuming responsibility for all cryogenic logistics activity, Cryoport expects to extend its support to include shipments at -80°C using its C3™ line of shippers as CCRM achieves scale.

Jerrell Shelton, CEO of Cryoport, said, "Our relationship with CCRM is truly exciting! CCRM is a distinguished leader and pioneer in fertility science and research. It supports a national network of award-winning physicians, a full suite of fertility services, innovative technology, and cutting-edge laboratories. CCRM helps thousands of families with fertility aspirations annually. We are confident of our growth strategy for the Reproductive Medicine market as we expand our reach globally."

Jon Pardew, CEO of CCRM, said, "Partnering with Cryoport to use their world-class supply chain solutions allows us to operate more efficiently across our enterprise, mitigate risks in our supply chain and better serve the intended parents that come to us with intentions to grow their families. Cryoport's size, scale and breadth of solutions make them the right partner to ensure we offer the highest quality experience available as we expand the reach of our business."

Related Posts

Subscribe Our Newsletter